Resurrected cancer drug faces regulators

Heidi Ledford

Nature, 2014, vol. 510, issue 7506, 454-454

Abstract: Despite a chequered history, olaparib is finally before the US Food and Drug Administration.

Date: 2014
References: Add references at CitEc
Citations:

Downloads: (external link)
https://www.nature.com/articles/510454a Abstract (text/html)
Access to the full text of the articles in this series is restricted.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:nat:nature:v:510:y:2014:i:7506:d:10.1038_510454a

Ordering information: This journal article can be ordered from
https://www.nature.com/

DOI: 10.1038/510454a

Access Statistics for this article

Nature is currently edited by Magdalena Skipper

More articles in Nature from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().